KUANTAN: A state-of-the-art pharmaceutical plant producing a new generation vaccine for dengue fever is to be built in Pahang, Mentri Besar Datuk Seri Adnan Yaakob said.
The entire project involving Russian technology is expected to take between four and five years.
“On March 4, a delegation comprising Pahang Technology Resources Sdn Bhd, Biopharma Today Sdn Bhd and Medical Today Sdn Bhd went on a trade mission to Russia and agreed on the transfer of technology from Russia to Malaysia,” Adnan told a press conference.
He said the project received the green light from the relevant authorities and the state government would allocate land, which is expected to be in Lanchang or Gambang.
Pahang Technology Resources CEO Sazali Mohd Nor said the estimated cost of the plant was US$30mil (RM90mil) with a further US$50mil (RM150mil) for dengue research and development.
Sazali said the intellectual property of the dengue fever vaccine would be co-shared by the Malaysian and Russian state agencies.
“The registration and marketing of the Russian drug are expected to be completed by mid-2014.
“The Russian technology will enable the facility to reduce the vaccine production time by half which is a crucial advantage given the rapid development of epidemics and pandemics around the world,” he said.
Sazali added that the project was not limited to dengue and the Malaysian market.
“The technological platform will create an opportunity to develop other original vaccines,” he said, adding that the technology transfer would pave the way for a breakthrough in nanotechnology in Malaysia.
No comments:
Post a Comment